OR WAIT null SECS
November 14, 2019
Phillips-Medisize, a Molex company, revealed that it is opening a new Global Innovation and Development (GID) office in Copenhagen, Denmark, to support its plans for growth.
A simulation-based drug discovery company, Turbine, has announced the closing of an institutional funding round worth EUR 3 million (US $3.3 million), which will be used to redesign the oncology drug discovery process.
Norwegian clinical-stage immunoncology company, Lytix Biopharma, has entered into a clinical collaboration with US-based Iovance Biotherapeutics.
A clinical-stage company that was spun out of the VUB university in Belgium, eTheRNA immunotherapies, has revealed it will be participating in an EU research project aimed at developing off-the-shelf mRNA nanomedicines.
November 07, 2019
The companies plan to promote and manufacture Maverick, an emergency-use, cartridge-based auto-injector.
The transaction is expected to be finalized in early 2020.
GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory platform to accelerate production of antibody drugs in the Guangzhou region.
November 06, 2019
Schott will combine its adaptiQ platform with West’s Ready Pack system.
November 02, 2019
Despite preparative work by the bio/pharma industry, any Brexit scenario will result in regulatory implications and increased costs.
After years of discussions around pricing, UK governmental bodies and Vertex have finally reached an agreement on cystic fibrosis treatments.